Update on NASDAQ Listing, Critical Metals Files Amendment to Form F-4

European Lithium Limited (ASX: EUR, FRA: PF8, OTC: EULIF) (European Lithium or the Company) is pleased to provide an update of progress on the proposed merger transaction and NASDAQ Listing.

On 26 October 2022, European Lithium announced that it has entered into a business combination agreement with Sizzle Acquisition Corp., (NASDAQ: SZZL) (Sizzle), a publicly traded special purpose acquisition company, pursuant to which EUR will combine its wholly owned Wolfsberg Lithium Project (Wolfsberg Project) with Sizzle via a newly-formed, lithium exploration and development company named “Critical Metals Corp.” which is expected to be listed on NASDAQ under the symbol “ CRML” (Transaction).

As previously advised, several amendments were lodged after the initial filling of the Form F-4 Registration Statement of Critical Metals Corp. (F-4 Registration Statement) with the U.S. SEC on 23 December 2022. Most recently, F-4 Amendment No 5 was filed with the SEC on 9 November 2023.

European Lithium shareholders approved the Transaction on 20 January 2023. Once the F-4 is declared effective by the SEC, the Sizzle Board will convene a shareholding meeting for purposes of, among other things, approving the Transaction.

The Transaction is progressing through the approval process and remains subject to SEC and Sizzle shareholder approval as outlined above.

Upon the closing of the Transaction, EUR will be issued US$750 million worth of ordinary shares in CRML.

Tony Sage, Chairman of EUR said “The company is excited that after a long and exhaustive process we are the final stages in seeking the SEC's approval to list on the NASDAQ.”

This announcement has been approved for release on ASX by the Board of Directors.

Click here for the full ASX Release

This article includes content from European Lithium, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.